Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the 7th Plant Genomics & Gene Editing Congress
November 05 2019 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company that uses its “Trait Factory” to develop high value seed
traits for the agriculture and food industries, today announced
that Kristi Snell, Ph.D., Yield10’s Chief Science Officer, will
present today at the 7th Plant Genomics & Gene Editing
Congress. The conference is being held November 4-5 in Raleigh,
North Carolina.
At the 7th Plant Genomics & Gene Editing Congress, Dr. Snell
will present a talk titled “Crop Trait Development: Target
selection and validation using the GRAIN Platform.” In the
presentation, Dr. Snell will discuss strategies the Yield10 team
has employed to identify and edit novel gene targets using CRISPR
genome editing to improve seed yield and oil content in oilseed
crops. Yield10 is using GRAIN 3.0 (“Gene Ranking Artificial
Intelligence Network”), a unique gene discovery platform that uses
metabolic insights obtained from metabolic modeling to mine
genomics data and prioritize gene selection for traits. This
platform allows the company to identify unique combinations of
traits to increase oil content and seed yield. Performance traits,
such as increased seed yield or oil content, can be combined with
oil composition traits, such as high oleic and omega fatty acids,
to develop high yielding, plant-based nutritional oils for use in
food and feed products.
“Over the last two years, we have expanded the capabilities of
our GRAIN platform to identify unique genes to deliver performance
traits such as increased yield. GRAIN 3.0 is unique in that it uses
predicted changes in metabolism, that are likely necessary to
enable a performance trait, to identify preferred genes to deliver
the trait,” said Dr. Snell, Ph.D., Chief Science Officer of Yield10
Bioscience. “Deploying our performance traits in Camelina could
transform the crop into an attractive platform for producing high
value products such as specialty oils while providing growers in
Canada and parts of the U.S. with an opportunity for crop
diversification. We look forward to further advancing our GRAIN
technology and deploying it to generate performance traits across
additional crops.”
A copy of Dr. Snell’s slide deck is available on the Yield10
Bioscience investor relations website.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
which uses its “Trait Factory” to develop high value seed traits
for the agriculture and food industries to achieve step-change
improvements in crop yield to enhance global food security and
develop specialty crop products. Yield10 has an extensive track
record of innovation based around optimizing the flow of carbon in
living systems. The “Trait Factory” has two components: the “GRAIN”
computational modeling platform, which is used to identify specific
gene changes designed to improve crop performance, and the
deployment of those changes into crops using genome-editing or
traditional agricultural biotechnology approaches. The purpose of
the “Trait Factory” is to engineer precise alterations to gene
activity and the flow of carbon in plants to produce higher yields
with lower inputs of land, water or fertilizer. Yield10 is
advancing several yield traits it has developed in crops such as
canola, soybean, rice, wheat and corn. Yield10 is headquartered in
Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon,
Canada.
For more information about the Company, please visit the website
and follow the Company on Twitter and LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, that the GRAIN computational platform may be able to
mine genomics data to identify novel gene targets and unique
combinations of traits to increase oil content and seed yield, that
the Company’s seed traits may achieve step-change improvements in
crop yield, that deploying the Company’s performance traits in
Camelina could transform the crop into an attractive platform for
producing high value products such as specialty oils while
providing growers in Canada and parts of the U.S. with an
opportunity for crop diversification, and that the Company will
enable the development of specialty crop products,
constitute forward-looking statements. Such forward-looking
statements are subject to a number of risks and uncertainties that
could cause actual results to differ materially from those
anticipated, including the risks and uncertainties detailed in
Yield10 Bioscience's filings with the Securities and Exchange
Commission. Yield10 assumes no obligation to update any
forward-looking information contained in this press release or with
respect to the matters described herein.
Contacts:
Yield10 Bioscience:Lynne H. Brum, (617) 682-4693,
LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
Marketing and PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Sep 2023 to Sep 2024